Nothing Works Without the Engine Running: Update on ADVANCED Heart Failure Management
9 March, 2023 1:00 p.m. to 2:00 p.m. EST
This webinar will discuss a variety of topics in the management of an advanced heart failure patient. The use of contemporary therapies such as ARNI, SGLTI, novel anticoagulants, amiodarone, ablation, and inotropes in a heart transplant or LVAD candidate, and the potential implications on transplantation and durable LVAD outcomes. Attendees will gain practical insights from expert speakers on the use of these HF therapies in patients awaiting heart transplantation or durable LVAD therapy.
Moderators:
Tara Veasey, PharmD, BCTXP
Carlos Ortiz Bautista MD, PhD
Alina Nicoara, MD
This presentation will discuss the role evidence for current standard of care in HF therapy medications (beta blockers, ARM, ARNI, MRA and SGLTI) in advanced HF patients, and the risks/ considerations specific to the advanced HF patient listed for transplant e.g., SGLT2 inhibitors and ketoacidosis. Can we extrapolate from clinical trials to advanced HF?
Presented by Georgina Waldman, PharmD, BCTXP
This presentation will review considerations for ’adjuvant’ medications typically used in advanced heart failure and transplant candidates, including anti-arrhythmic (e.g. amiodarone), antiplatelets (DAPT e.g. recent PCI), anticoagulants (in particular DOACS: AntiXa and direct thrombin inhibitors in those listed for MCS or Transplant), and inotropes. Do short term benefits outweigh post-transplant risks?
Presented by Doug Jennings, PharmD
This presentation will describe an overview of specifics of heart failure management in children, the underlying pediatric evidence and adaption and divergence of evidence generated in adult trials. It will further outline aspects of heart failure management in adults and children with congenital hearts disease including single ventricle and failing Fontan physiology.
Presented by Paul Kantor, MBBCh, MSc, FRCPC
This presentation will discuss if should we go straight to transplant or LVAD, or is there a role for valve intervention, ablation (VT, AV node+CRT) and other devices in advanced HF/ transplant candidates. Devices in advanced HF (resynchcronisation, edge to edge for mitral or tricuspid).
Presented by Guillaume Coutance, MD
Led by Moderators
